As for the anti-inflammatory factors IL-4 and IL-10 (Figure 6b), compared with the normal group, their relative expression in the NAFLD group were significantly increased to 1.8 ± 0.34 and 2.01 ± 0.84 times. Here, IL4 is linked to metabolic dysfunction-associated steatotic liver disease.